Nichi-Iko acquires majority of shares in Binex

Published: 2013-10-07 07:00:00

Updated: 2013-10-07 07:00:00

Japan’s leading generic drugmaker Nichi-Iko Pharmaceutical Co. has acquired a majority share (12.6 percent stake) in Binex Co. through a combination of new shares issued by Binex to Nichi-Iko and the acquisition of shares owned by existing shareholders, Binex officials said in its regulatory fili...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK